Most Recent

image: How to Build Bioinformatic Pipelines Using Galaxy

How to Build Bioinformatic Pipelines Using Galaxy

By | August 1, 2016

A point-and-click interface alternative to command-line tools that allows researchers to easily create, run, and troubleshoot serial sequence analyses

0 Comments

image: Software for Image Analysis

Software for Image Analysis

By | August 1, 2016

Profiles of five programs for quantifying data from Westerns, dot blots, gels, and colony cultures

0 Comments

image: Composite Endpoints in Clinical Trials

Composite Endpoints in Clinical Trials

By | July 1, 2016

There’s a right way and a wrong way to boost the statistical sensitivity of this type of clinical studies.

1 Comment

image: The Genetic Components of Rare Diseases

The Genetic Components of Rare Diseases

By | July 1, 2016

Techniques for determining which genes or genetic variants are truly detrimental

0 Comments

image: Enhancing Vaccine Development

Enhancing Vaccine Development

By | June 1, 2016

Using proteomics methods to inform antigen selection

1 Comment

image: Making Micromotors Biocompatible

Making Micromotors Biocompatible

By | June 1, 2016

Researchers are developing potent ways to fuel and control the movement of micromotor devices.

0 Comments

image: Becoming Acculturated

Becoming Acculturated

By | May 1, 2016

Techniques for deep dives into the microbial dark matter

0 Comments

image: Scaling to Singles

Scaling to Singles

By | May 1, 2016

Tips for tracing transcription in individual cells

0 Comments

image: Pulling It All Together

Pulling It All Together

By | April 1, 2016

Systems-biology approaches offer new strategies for finding hard-to-identify drug targets for cancer.

0 Comments

image: Dial It Up, Dial It Down

Dial It Up, Dial It Down

By | March 1, 2016

Newer CRISPR tools for manipulating transcription will help unlock noncoding RNA’s many roles.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Streakers, Poopers, and Performers: The Wilder Side of Wildlife Cameras
AAAS